X0202 5 2004-12-31 0 0 0 0000761237 IMCOR PHARMACEUTICAL CO ICPHC 0001140484 OXFORD BIOSCIENCE PARTNERS IV LP 222 BERKELEY STREET, SUITE 1650 BOSTON MA 02216 0 0 1 0 Common Stock 2004-09-28 5 A 0 335099 0.13 A 43491797 D Common Stock 2004-10-28 5 A 0 726049 0.06 A 44217846 D Common Stock 2004-11-28 5 A 0 217815 0.20 A 44435661 D Common Stock 2004-12-28 5 A 0 79205 0.55 A 44514866 D Pursuant to Section 2(c) of the Issuer's Registration Rights Agreements dated April 19, 2004 and June 30, 2004, the Issuer issued such shares as liquidated damages in respect of the delayed effectiveness of the Issuer's resale registration statement for the applicable period. Prior to receiving the shares in respect of the late effectiveness of the resale registration statement, the reporting person adjusted the holdings it reported on July 2, 2004 of 43,333,382 to reflect a decrease of 176,684 shares of common stock to correct a miscalcuation of shares issued in connection with the prior conversion of interest payments, resulting in a revised opening balance for this Form 5 of 43,156,698. /s/ Alexia Pearsall, under power of attorney for Jonathan Fleming, general partner of OBP Management IV L.P., its general partner 2005-02-17